Icbii
1 known investors
ICBI develops biologics based on its SMART Molecule Technology Platform that cross the blood-brain barrier to target pathologic proteins in the central nervous system, aimed at early diagnosis, monitoring, and treatment of Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. The company is preparing Phase 1 clinical trials for its therapeutic and diagnostic candidates.
BiotechDeep TechDigital Health
Investors Β· 1
Frequently asked questions
- What does Icbii do?
- ICBI develops biologics based on its SMART Molecule Technology Platform that cross the blood-brain barrier to target pathologic proteins in the central nervous system, aimed at early diagnosis, monitoring, and treatment of Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases. The company is preparing Phase 1 clinical trials for its therapeutic and diagnostic candidates.
- Who are Icbii's investors?
- Icbii's investors include Solve Ventures.